ArticleAmerican journal of cancer research2019

Randomized phase II study of pemetrexed-cisplatin or docetaxel-cisplatin plus thoracic intensity-modulated radiation therapy in patients with stage IV lung adenocarcinoma.

Sheng-Fa Su et al.PubMed ↗Full text ↗

No numbers read from the abstract.